Jaguar Health Reports Q3 2026 Revenue of $2.3 Million and Lower Net Loss
Jaguar Health reported third-quarter 2026 revenue of $2.3 million and a net loss of $5.8 million. The company’s operating loss narrowed to $6.0 million, while non-GAAP recurring EBITDA was a loss of $5.0 million. Jaguar also said it reduced its outstanding debt balance by $10.1 million during the q…